XML 53 R47.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Acquisitions - Summary of Purchase Price Allocation for Acquired Identifiable Assets, Liabilities Assumed and Goodwill (Detail) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
Apr. 10, 2023
Mar. 30, 2024
Dec. 30, 2023
Dec. 31, 2022
Liabilities assumed:        
Total goodwill   $ 242,258 $ 243,441 $ 155,998
Weekend Health, Inc. d/b/a Sequence        
Total consideration:        
Cash paid at closing $ 64,217      
Cash to be paid on April 10, 2024 16,000      
Cash to be paid on April 10, 2025 16,000      
Aggregated merger consideration 132,000      
Assets acquired:        
Cash 25,800      
Weekend Health, Inc. d/b/a Sequence | Purchase Price Allocation        
Total consideration:        
Cash paid at closing 64,217      
Cash to be paid on April 10, 2024 16,000      
Cash to be paid on April 10, 2025 [1] 12,420      
Payments in Cash to Acquire Businesses, Total 92,637      
Less stock-based compensation expense attributable to post combination vesting (3,882)      
Aggregated merger consideration 121,698      
Assets acquired:        
Cash 25,776      
Prepaid expenses and other current assets 2,220      
Property, plant and equipment 34      
Intangible assets 7,222      
Total assets acquired 35,252      
Liabilities assumed:        
Accounts payable 70      
Accrued liabilities 14      
Deferred revenue 1,300      
Deferred tax liability 1,912      
Total liabilities assumed 3,296      
Net assets acquired 31,956      
Total goodwill $ 89,742      
Weekend Health, Inc. d/b/a Sequence | Common Stock        
Total consideration:        
Common shares issued 7,996      
Stock price as of April 10, 2023 $ 4.34      
Weekend Health, Inc. d/b/a Sequence | Common Stock | Purchase Price Allocation        
Total consideration:        
Common shares issued 7,996      
Stock price as of April 10, 2023 [2] $ 4.12      
Total stock issuance purchase price [2] $ 32,943      
[1] Reflects $16,000 of cash payable on April 10, 2025 as Merger Consideration discounted using the Company’s weighted average cost of debt.
[2] Represents the fair value of the shares transferred to the sellers as Merger Consideration, based on the number of shares to be issued, 7,996, multiplied by the closing price of the Companys ordinary shares on April 10, 2023 of $4.12 per share.